Regennova logo — Pioneering the future of medicine for inflammatory and neuro...

Regennova

Pioneering the future of medicine for inflammatory and neurological challenges like Cerebral Stroke, Traumatic Brain Injury, and Alzheimer's disease.

Founded 2022 Grant Total: $5.00K Biopharma, Biotechnology

General Information

Company Name Regennova
Founded Year 2022
Industries Biopharma, Biotechnology
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Regennova. To contact Regennova, visit regennova.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Regennova compare?

A PDF of Regennova and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Regennova soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Regennova

Regennova, a biotech startup founded in 2022, is pioneering the future of medicine for inflammatory and neurological challenges such as Cerebral Stroke, Traumatic Brain Injury, and Alzheimer's disease. The company's dedication to developing innovative medicines for these illnesses has attracted the attention of investors, with First Flight Venture Center providing a $5.00K grant investment on 10 August 2022. Regennova operates in the Biopharma and Biotechnology industries, positioning itself at the forefront of medical innovation. With its focus on addressing critical medical needs, Regennova presents a promising prospect for venture capitalists seeking to support the advancement of healthcare solutions.

Business keywords: Biotech, Medicine, Innovation, Inflammatory Diseases, Neurological Disorders, Cerebral Stroke, Traumatic Brain Injury, Alzheimer's Disease, Research, Development, Medical Technology, Pharmaceuticals

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $5.00K 1
First Flight Venture Center
10 Aug 2022

Regennova Alternatives & Competitors

View All Alternatives
Regennova vs
Novoron Bioscience
Novoron Bioscience United States

Pioneering lipoprotein-receptor drug development to repair damage and degeneration to the brain, spi...

Seed
17 employees
Biopharma, Biotechnology
Regennova vs

Harnessing the Power of Mitochondria to Create Resilient, Protective Cells in Neurodegeneration and...

Venture round
4 employees
Biopharma, Biotechnology
Regennova vs
Bloom Science, Inc.
Bloom Science, Inc. United States

Leveraging the Gut-Brain Axis to Drive Therapeutic Innovation

Series A
17 employees
Biopharma, Biotechnology

FAQ About Regennova

Pioneering the future of medicine for inflammatory and neurological challenges like Cerebral Stroke, Traumatic Brain Injury, and Alzheimer's disease.
Regennova was founded in 2022.
Regennova operates in Biopharma and Biotechnology. Its work centres on Biotech, Medicine, Innovation and Inflammatory Diseases.
Regennova has completed 1 funding round, raising a total of $5.00K. The latest funding stage is Grant.
Top alternatives and competitors to Regennova include Novoron Bioscience, Mitochon Pharmaceuticals, Inc., Bloom Science, Inc., NsGene A/S, BIORCHESTRA Co., Ltd.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Regennova and Novoron Bioscience are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Regennova, https://bouncewatch.com/company/regennova, updated 10 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes